Last reviewed · How we verify
NCT07344493: ANKMIL
Average ANKLE GO Score in the Objective Functional Assessment of the Ankle in Healthy Military Personnel (ANKMIL)
trial in Ankle Disorders Injuries in 96 participants. Completed in 8 November 2025.
8 November 2025
Quick facts
| Lead sponsor | Direction Centrale du Service de Santé des Armées |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 96 |
| Start date | 7 October 2025 |
| Primary completion | 8 November 2025 |
| Estimated completion | 8 November 2025 |
| Sites | 1 location across France |
Conditions studied
- Ankle Disorders Injuries — all drugs for Ankle Disorders Injuries →
Sponsor
Direction Centrale du Service de Santé des Armées — full company profile →
Who can join
18 and older, any sex, with Ankle Disorders Injuries. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research aims to establish reference values for the Ankle-Go score, a validated tool for functional assessment of the ankle, in healthy military personnel. The Ankle-Go score, already used in the civilian population after sprains or surgery, combines physical tests and subjective questionnaires to assess functional recovery of the ankle. No normative data currently exist for the military population, whose physical and operational requirements differ significantly from those of the general population. This is an observational, prospective, single-center study conducted at the 39th medical branch in Oberhoffen (5th CMA). It will include 96 active military personnel with healthy ankles, examined during their periodic medical visit. Participants will complete the full Ankle-Go test and fill out the associated questionnaires on the secure anklego.com platform. The data will then be analyzed anonymously to calculate a reference average and explore possible variations according to gender and age. These results will ultimately improve care and fitness-to-duty decisions after ankle injuries in the military. The total duration of the study is estimated at 8 months, including 6 months of data collection and 2 months of analysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07344493
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Direction Centrale du Service de Santé des Armées trials
Trials by the same sponsor.
- NCT07352904 — Exploration Strategies in Night Vision Sensors · not yet recruiting
- NCT06996275 — Attachment and Post-Traumatic Stress Disorder in Military Personnel: Characterization of the French Military Population, · not yet recruiting
- NCT06490029 — Diagnostic of Various Ototoxicity Induced by Cancer Treatment · recruiting
- NCT06174181 — Preventive TREatment of Dry Eye in Patients Receiving Repeated Intravitreal Injections for Age-related Macular Degenerat · NA · completed
- NCT05993533 — Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Thera · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07344493 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Direction Centrale du Service de Santé des Armées
- Last refreshed: 15 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07344493.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing